REVISING PHASE-IN OF MEDICARE CLINICAL LABORATORY TEST PAYMENT CHANGES.

SEC. 6209. REVISING PHASE-IN OF MEDICARE CLINICAL LABORATORY TEST PAYMENT CHANGES. (a) Revised Phase-in of Reductions From Private Payor Rate Implementation.—Section 1834A(b)(3)(B) of the Social Security Act (42 U.S.C. 1395m-1(b)(3)(B)) is amended— (1) in clause (ii), by inserting “and for the period beginning on January 1, 2026, and ending on January 30, 2026” after “2025”; and (2) in clause (iii), by striking “for each of 2026 through 2028” and inserting “for the period beginning on January 31, 2026, and ending on December 31, 2026, and for each of 2027 and 2028”. (b) Revised Reporting Period for Reporting of Private Sector Payment Rates for Establishment of Medicare Payment Rates.—Section 1834A(a)(1)(B) of the Social Security Act (42 U.S.C. 1395m-1(a)(1)(B)) is amended— (1) in clause (i), by striking “December 31, 2025” and inserting “January 31, 2026”; and (2) in clause (ii), by striking “January 1, 2026, and ending March 31, 2026” and inserting “February 1, 2026, and ending April 30, 2026”.